Dr. Peter Schiemann

Peter is co-founder and Business Development Manager of iQure Pharma Inc. Peter began his career in research while working on his PhD thesis in 1992 when he also managed a research grant and led a team of researchers in molecular and cell biology. He left research to join Roche in Switzerland in 1996 to lead the in-process control group in trade packaging and worked as the head of the Clinical Supplies packaging and labeling plant. In 1999, Peter joined PricewaterhouseCoopers’ R&D Strategy consulting group. He led several projects with large and small Pharma/Biotech companies in Europe and the US helping them to establish more robust strategies and processes, e.g. supply chain, document management, R&D strategy and supporting organization, etc. Peter rejoined Roche in the US in 2003 and forged a strategic alliance with a CRO in auditing clinical trial centers. In 2004, he initiated the Quality Risk Management (QRM) project which was successfully implemented in 2009.

​

Peter left Roche in 2011 to co-found Widler & Schiemann Ltd, a management consulting firm specializing in supporting their clients in drug development of new medications.

​

In 2016 he moved to China to further build the business and founded the subsidiary of Widler & Schiemann Ltd. in Shanghai. In 2018, Peter moved to the US to further build Widler & Schiemann’s business. In 2019 Peter and five colleagues founded iQure Pharma Inc. to develop novel medications sourced from Universities and independent researchers.